BEVERLY J MASER
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family DOVER, DE NPI 1487932232
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family DE Novo Nordisk AS All categories
General Payments — all program years on this page
$578.23
- Category: General Payments
- Program years: PY2021–2024
- Record count: 13
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $321.18 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $321.18 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $125.00 | 1 |
| Acerta Pharma LLC | $71.72 | 1 |
| Merck Sharp & Dohme Corporation | $42.49 | 2 |
| Gilead Sciences, Inc. | $41.26 | 2 |
| Insmed, Inc. | $21.54 | 1 |
| ViiV Healthcare Company | $19.17 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089562414 | Insmed, Inc. | $21.54 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100590574 | Novo Nordisk Inc | $125.00 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105546097 | AstraZeneca Pharmaceuticals LP | $71.72 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1112699767 | ViiV Healthcare Company | $19.17 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133671002 | Gilead Sciences, Inc. | $15.21 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133671004 | Gilead Sciences, Inc. | $26.05 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141784263 | Merck Sharp & Dohme LLC | $18.50 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141941199 | Merck Sharp & Dohme LLC | $23.99 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.